Skip to content
Up to 30% Off on all Treatments
AIIMS Trained DermatologistsEvidence First, Root Cause CareSafe for Fitzpatrick IV–VI
Free skin analysis & personalised plan 📞 +91 9717503031 🌐 www.allodermis.com Free skin analysis & personalised plan 📞 +91 9717503031 🌐 www.allodermis.com
Melasma Treatment

Melasma Treatment at Allodermis

Restore even tone. Treat the cause. Keep the results.

Melasma is common, stubborn and emotionally heavy. Our dermatologists map the type, depth and triggers of your pigmentation, treat skin biology from the inside out, and combine safe, evidence-backed procedures with maintenance plans that minimise recurrence and protect your skin long term.

Book a Consultation

Free skin analysis & personalised plan — 5-minute callback

Or call 📞 +91 9717503031

4.9 ★ Google Rating AIIMS Trained Dermatologists Evidence First Root Cause Care 4.9 ★ Google Rating AIIMS Trained Dermatologists Evidence First Root Cause Care
Why Allodermis

Why Allodermis for melasma?

We treat melasma as medicine, not marketing. Every plan starts with diagnostics.

01

Root-cause approach

Hormones, inflammation, barrier dysfunction and photodamage are investigated — not only surface pigment.

02

MD-led care

Treatment delivered and reviewed by AIIMS trained dermatologists.

03

Personalised protocols

Topical, systemic, peel, device and procedural options are chosen only after diagnostics.

04

Safe for Indian skin

Equipment and protocols selected to minimise post-inflammatory hyperpigmentation.

05

Sustainable outcomes

Short-term improvement paired with a long-term maintenance plan.

Start your personalised plan

Free 5-minute callback from an MD dermatologist.

Book now
What is it

What is melasma?

Melasma is patterned hyperpigmentation caused by melanocyte overstimulation. It most commonly affects women of reproductive age and darker phototypes, but men can have it too.

Triggers include UV exposure, pregnancy, hormonal therapy, thyroid disease, inflammation and some drugs. Which of these is driving your pigment decides what will actually work — and what will make it worse.

Typical areasCheeks, forehead, nose, upper lip, jawline
TypesEpidermal, dermal, mixed
Visible improvementOften within 4–8 weeks with a tailored plan; maintenance needed
Indicative pricingTopical ₹500–3,000/month; peels ₹4,500–7,000; lasers ₹9,000–12,000/session

We treat melasma as medicine — not marketing.

Diagnosis matters

The three types of melasma

Depth decides the protocol. Treating a dermal pattern like an epidermal one is how melasma gets worse.

Type 01Epidermal

Superficial, brown, clearly highlighted on Wood’s lamp — best response to topical, peel and laser strategies.

Type 02Dermal

Deeper, bluish-grey, less responsive — needs cautious multimodal therapy.

Type 03Mixed

Elements of both — common in Indian skin, needs combination plans.

Clinical pathway

How we diagnose

01

Detailed history

Where the trigger usually hides

Hormones, medications, cosmetics, heat and sun exposure, pregnancy.

02

Clinical examination

Wood’s lamp & dermoscopy

Establishes whether the pigment is epidermal, dermal or mixed before anything is prescribed.

03

Phototype & barrier assessment

Risk profiling

Determines safe device settings and how aggressively topicals can be introduced.

04

Targeted blood tests

Where indicated

Thyroid and hormone panels, ordered only when the history points to an endocrine contributor.

05

Melanin depth mapping

Guides treatment choice

The output of this step is what your treatment combination is built from.

Treatment roadmap

Evidence-based, in sequence

All plans begin with barrier repair, sun strategy and anti-inflammatory control. We then select personalised combinations.

01Foundation: Sun & Barrier RepairAlways first+

Nothing else holds without this layer in place.

  • Broad-spectrum physical sunscreen SPF 50+, reapplied
  • Anti-inflammatory, barrier-repair moisturisers
  • Avoidance of heat & phototoxic agents
Why firstSome topical cosmetics are themselves phototoxic and keep the pigment cycle running.
02Medical topicalsFirst line+

Hydroquinone is used in supervised short courses only. Azelaic acid, kojic acid, niacinamide and photostable vitamin C serve as adjuncts for maintenance.

  • Tranexamic acid (topical)
  • Hydroquinone 2–4%
  • Retinoids (tretinoin / adapalene)
  • Azelaic acid
  • Kojic acid
  • Niacinamide
  • Vitamin C (photostable)
MechanismTranexamic acid reduces melanogenesis via the plasmin pathway; retinoids increase turnover and enhance penetration.
03Oral systemicSelect cases only+

Oral tranexamic acid, under strict medical supervision, for refractory melasma or hormonally driven cases. Endocrine contributors are investigated and treated in parallel.

  • Oral tranexamic acid
  • Thyroid review
  • Contraceptive review
EligibilityNot everyone is a candidate. Screening and monitoring are mandatory.
04Chemical peelsSuperficial to medium, tailored+

Chosen after priming, and typically repeated every 3–4 weeks — the exact protocol varies by peel and by patient.

  • Glycolic
  • Lactic
  • Mandelic
  • Salicylic blends
  • TCA (low / medium)
SequencingPriming is what separates a controlled peel from a PIH trigger.
05Laser & device optionsUsed carefully, MD supervised+

Q-switched Nd:YAG and low-fluence laser toning are effective for deeper pigment when used cautiously. Fractional non-ablative resurfacing is reserved for mixed lesions and textural benefit. Microneedling works in combination with topical modulators under a careful protocol to avoid PIH.

  • Q-switched Nd:YAG
  • Low-fluence laser toning
  • Fractional non-ablative resurfacing
  • Microneedling + topical modulators
CautionDevices are selected for phototype, not for speed of result.
06Combination therapy & maintenanceWhere results are kept+

A maintenance topical regimen with seasonal boosters, plus lifestyle and hormonal management where needed, to reduce recurrence.

  • Maintenance topicals
  • Seasonal peel / laser boosters
  • Lifestyle & hormonal management
Why it mattersRecurrence is common if triggers persist — maintenance is part of the treatment, not an upsell.
Treatment journey

An example plan

01

Week 0–2

Skin priming — barrier repair, sunscreen and starting topical agents.

02

Week 4

First superficial peel if indicated, or start low-fluence laser dosing.

03

Week 6–12

Repeat procedures as required; oral tranexamic acid introduced only if indicated.

04

Maintenance

Daily topical maintenance and quarterly clinic reviews.

Safety

What we counsel you on

Melasma is one of the few conditions where the wrong treatment reliably makes things worse. We say this before you start, not after.

01
Procedure riskIrritation & PIH
  • Risk of irritation and transient redness
  • Rarely, post-inflammatory hyperpigmentation — especially without priming
02
Medication riskHydroquinone misuse
  • Misuse can cause ochronosis
  • Courses are monitored and time-limited
03
Device riskImproper laser use
  • Lasers can worsen pigmentation if improperly used
  • MD-supervised protocols and lower fluences for higher phototypes
Indicative costs

Melasma treatment cost in India

A custom quote is required — these are indicative ranges only.

₹500 – ₹12,000
Per session or monthly program
Final pricing depends on
  • Diagnosis
  • Area treated
  • Number of sessions
  • Combination treatments

Modality-wise indicative cost

  • Topical Medical Program (monthly) — ₹500 – ₹3,000
  • Superficial Chemical Peel — ₹4,500 – ₹7,000
  • Medium Peel / Cosmelan (protocol) — On request
  • Laser Toning (Q-Switched Nd:YAG) — ₹9,000 – ₹12,000
  • Oral Tranexamic Acid (medical course) — ₹2,000 – ₹6,000, consultation needed
Results

Before & after

Case 01Client ALO-MEL-012 — mixed melasma: 60% clinical lightening after 6 sessions (peel + topical + oral tranexamic acid)
Case 02Epidermal melasma — topical program + superficial peels
Case 03Dermal melasma — low-fluence laser toning + maintenance

Individual results vary. All photographs are captured to a fixed standard — same lighting, same angle, time-stamped, with patient consent.

FAQ

Questions we hear most often

Can melasma be permanently cured?

Melasma is chronic for many. It can be controlled very effectively with correct diagnosis, treatment and maintenance — but recurrence is common if triggers persist.

Is laser safe for Indian skin tones?

Yes — when performed by experienced dermatologists using appropriate devices and settings, with priming to reduce PIH risk.

How soon will I see results?

Some improvement from topicals and peels in 4–8 weeks; full protocols may take 3–6 months.

Is oral tranexamic acid safe?

When prescribed by an MD with proper screening and monitoring, it is a useful option for resistant melasma. Not everyone is eligible.

Can I use over-the-counter “brightening” creams?

Many OTC products irritate and worsen melasma. Always consult a dermatologist before starting new agents.

Ready to begin?
Even tone, kept even.

Free skin analysis and a personalised plan from AIIMS trained dermatologists.

📞 +91 9717503031

🌐 www.allodermis.com

Book Consultation
Clinical references

Further reading

  1. Sarkar R, Ranjan R, Garg S, Garg VK, Sonthalia S, Bansal S. Periorbital Hyperpigmentation: A Comprehensive Review. Journal of Clinical and Aesthetic Dermatology. 2016;9(1):49–55. https://pmc.ncbi.nlm.nih.gov/articles/PMC4756872/
  2. Konisky H, Balazic E, Jaller JA, Khanna U, Kobets K. Tranexamic Acid in Melasma: A Focused Review on Drug Administration Routes. Journal of Cosmetic Dermatology. 2023;22(4):1157–1162. https://pubmed.ncbi.nlm.nih.gov/36606378/
  3. Aurangabadkar SJ. Optimizing Q-Switched Lasers for Melasma and Acquired Dermal Melanoses. Indian Journal of Dermatology, Venereology and Leprology. 2019;85(1):10–17. https://pubmed.ncbi.nlm.nih.gov/30027914/
  4. Rendon MI, Berson DS, Cohen JL, Roberts WE, Starker I, Wang B. Evidence and Considerations in the Application of Chemical Peels in Skin Disorders and Aesthetic Resurfacing. Journal of Clinical and Aesthetic Dermatology. 2010;3(7):32–43. https://pmc.ncbi.nlm.nih.gov/articles/PMC2921757/
  5. Silpa-Archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory Hyperpigmentation: A Comprehensive Overview — Epidemiology, Pathogenesis, Clinical Presentation, and Noninvasive Assessment Techniques. Journal of the American Academy of Dermatology. 2017;77(4):591–605. https://pubmed.ncbi.nlm.nih.gov/28941441/
Written by

Swaraj Dhar

Co Founder, Allodermis | Entrepreneur

LinkedIn →
🩺
Reviewed by

Dr. Alok

Co Founder, Allodermis | Clinical Dermatology Lead, Founder Alloroots

LinkedIn →
AI Skin Analysis